Moderna, Inc.
MRNA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001682852
In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 4 insiders, $49.2M in total
- Insiders trading
- 4
- Net value
- −$49.2M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hoge Stephen | President | 1,562,029 | Sep 16, 2026 | 13 |
| Mock James M | Chief Financial Officer | 59,375 | Sep 14, 2026 | 16 |
| Klinger Shannon Thyme | Chief Legal Officer | 81,340 | Sep 8, 2026 | 12 |
| Bancel Stephane | Chief Executive Officer | 6,440,260 | Aug 7, 2026 | 4 |
| McDonnell Michael R | Director | – | Jul 10, 2026 | 1 |
| Banque Soria Ester | Chief Commercial Officer | – | Jul 7, 2026 | 1 |
| Afeyan Noubar | Director | 3,924Indirect | May 22, 2026 | 3 |
| Tallett Elizabeth E | Director | 4,761 | May 8, 2026 | 2 |
| Nader Francois | Director | 32,781 | May 8, 2026 | 2 |
| Rubenstein David M. | Director | 9,643 | May 8, 2026 | 2 |
| Nabel Elizabeth G | Director | 19,317 | May 8, 2026 | 2 |
| Horning Sandra | Director | 18,585 | May 8, 2026 | 2 |
| Hussain Abbas | Director | 12,066 | May 8, 2026 | 4 |
| Sagan Paul | Director | 312,027Indirect | May 1, 2025 | 0 |
| Langer Robert | Director | 11,467,664 | May 7, 2024 | 0 |
| Berenson Stephen | Director | 22,203 | May 7, 2024 | 0 |
| Garay Arpa | Chief Commercial Officer | 3,690 | Dec 7, 2023 | 0 |
| Andres Juan | See remarks | 12,803 | Dec 30, 2022 | 0 |
| Burton Paul | Chief Medical Officer | 954 | Nov 8, 2022 | 0 |
| Meline David W | Chief Financial Officer | 2,857 | Aug 11, 2022 | 0 |
| Zaks Tal Zvi | Chief Medical Officer | 0 | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2021 (view filing) | Jul 14 | 2 days | Andres JuanSee remarks | SSale | −5.00K | $237.22 | −$1.19M | −100.0%0 after | |
| Jul 16, 2021 (view filing) | Jul 14 | 2 days | Bancel StephaneChief Executive Officer | SSale | −9.00K | $237.22 | −$2.13M | −0.1%6.22M after | |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Bancel StephaneChief Executive Officer | SSale | −10.0K | $246.66 | −$2.47M | −0.1%7.32M after | |
| Jul 14, 2021 (view filing) | Jul 12 | 2 days | Andres JuanSee remarks | SSale | −5.00K | $230.71 | −$1.15M | −100.0%0 after | |
| Jul 14, 2021 (view filing) | Jul 12-13 | 2 days | Hoge StephenPresident | SSale | −20.0K | $236.83 | −$4.74M | −1.2%1.61M after | 2 lots |
| Jul 9, 2021 (view filing) | Jul 7 | 2 days | Andres JuanSee remarks | SSale | −5.00K | $231.76 | −$1.16M | −100.0%0 after | |
| Jul 9, 2021 (view filing) | Jul 7 | 2 days | Bancel StephaneChief Executive Officer | SSale | −9.00K | $231.76 | −$2.09M | −0.1%6.23M after | |
| Jul 9, 2021 (view filing) | Jul 8 | 1 day | Bancel StephaneChief Executive Officer | SSale | −10.0K | $216.07 | −$2.16M | −0.1%7.33M after | |
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Hoge StephenPresident | SSale | −10.0K | $229.62 | −$2.30M | −0.6%1.61M after | |
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Andres JuanSee remarks | SSale | −5.00K | $229.62 | −$1.15M | −100.0%0 after | |
| Jul 6, 2021 (view filing) | Jul 2 | 4 days | Hoge StephenPresident | SSale | −10.0K | $235.21 | −$2.35M | −0.6%1.61M after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Andres JuanSee remarks | SSale | −5.00K | $237.00 | −$1.19M | −100.0%0 after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Zaks Tal ZviChief Medical Officer | SSale | −5.00K | $237.00 | −$1.19M | −100.0%0 after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Bancel StephaneChief Executive Officer | SSale | −9.00K | $237.00 | −$2.13M | −0.1%6.24M after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Bancel StephaneChief Executive Officer | SSale | −10.0K | $236.14 | −$2.36M | −0.1%7.34M after |